Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China

Chinese Medical Journal

Volumn 125, Issue 4, 2012, Pages 639-645

  Yang, Yan ^a   Xu, Feng ^a   Shi, Li Yun ^b   Diao, Ran ^a   Cheng, Yu Sheng ^a   Chen, Xi Yuan ^a   Jing, Ji Yong ^a   Wang, Xuan Ding ^a   Shen, Hua Hao ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

Community acquired pneumonia; CURB 65 score; Intensive care unit treatment; Pneumonia severity; Pneumonia severity index; Sepsis score

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CEREBROVASCULAR DISEASE; CHINA; CHRONIC KIDNEY FAILURE; CHRONIC LIVER FAILURE; CLINICAL EFFECTIVENESS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; CURB 65 INDEX; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART DISEASE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA SEVERITY INDEX; PREDICTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SEPSIS SCORE; SMOKING; TUMOR;

ADULT; AGED; CHINA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84863144339     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.04.015     Document Type: Article

References (26)

1. Ramirez JA. Community-acquired pneumonia in adults. Prim Care 2003; 30: 155-171.
2. The guideline of community acquired pneumonia diagnosis and treatment in China. Chin J Tuberc Respir Dis (Chin) 2006; 29: 651-655.
3. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
4. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-382.
5. Spindler C, Ortqvist A. Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia. Eur Respir J 2006; 28: 816-823.
6. Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008; 31: 349-355.
7. Bauer TT, Ewig S, Marre R, Suttorp N, Welte T. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006; 260: 93-101.
8. Schaaf B, Kruse J, Rupp J, Reinert RR, Droemann D, Zabel P, et al. Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia. Eur Respir J 2007; 30: 517-524.
9. Dremsizov T, Clermont G, Kellum JA, Kalassian KG, Fine MJ, Angus DC. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest 2006; 129: 968-978.
10. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997; 112: 235-243.
11. Renaud B, Coma E, Hayon J, Gurgui M, Longo C, Blancher M, et al. PNEUMOCOM study investigators. Investigation of the ability of the Pneumonia Severity Index to accurately predict clinically relevant outcomes: a European study. Clin Microbiol Infect 2007; 13: 923-931.
12. Barlow G, Nathwani D, Davey P. The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax 2007; 62: 253-259.
13. Ewig S, de Roux A, Bauer T, García E, Mensa J, Niederman M, et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004; 59: 421-427.
14. Xu F, Droemann D, Rupp J, Shen H, Wu X, Goldmann T, et al. Modulation of the inflammatory response to Streptococcus pneumonia in a model of acute human lung tissue infection. Am J Respir Cell Mol Biol 2008; 39: 552-559.
15. Dremsizov T, Clermont G, Kellum JA, Kalassian KG, Fine MJ, Angus DC. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest 2006; 129: 968-978.
16. Otero RM, Nguyen HB, Huang DT, Gaieski DF, Goyal M, Gunnerson KJ, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 2006; 130: 1579-1595.
17. Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K. Outcome of CAP: influence of age, residence status, and antimicrobial treatment. Eur Respir J 2008; 32: 139-146.
18. Rodriguez A, Lisboa T, Blot S, Martin-Loeches I, Solé-Violan J, De Mendoza D, et al. Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. Intensive Care Med 2009; 35: 430-438.
19. Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest 2008; 133: 610-617.
20. Valencia M, Badia JR, Cavalcanti M, Ferrer M, Agustí C, Angrill J, et al. Pneumonia severity index class V patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest 2007; 132: 515-522.
21. Chalmers JD. ICU admission and severity assessment in community-acquired pneumonia. Crit Care 2009; 13: 156.
22. Phua J, Ngerng WJ, Lim TK. The impact of a delay in intensive care unit admission for community-acquired pneumonia. Eur Respir J 2010; 36: 826-833.
23. Chen CZ, Fan PS, Lin CC, Lee CH, Hsiue TR. Repeated pneumonia severity index measurement after admission increases its predictive value for mortality in severe community-acquired pneumonia. J Formos Med Assoc 2009; 108: 219-223.
24. Yandiola PP, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, et al. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest 2009; 135: 1572-1579.
25. File TM Jr, Monte SV, Schentag JJ, Paladino JA, Klugman KP, Lavin B, et al. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic. Int J Antimicrob Agents 2009; 33: 58-64.
26. Torres A, Menéndez R. Mortality in COPD patients with community-acquired pneumonia: who is the third partner? Eur Respir J 2006; 28: 262-263.